The European Community Respiratory Health Survey II

The European Community Respiratory Health Survey (ECRHS) II will determine the incidence of and risk factors for the development of allergic disease, atopy and rapid loss of lung function in middle-aged adults living in Europe. From 1991–1993, >18,000 individuals took part in ECRHS I and provided information on symptoms and exposure to known or suspected risk factors for asthma. Blood samples for assessment of specific immunoglobulin E to environmental allergen were taken and lung function and bronchial responsiveness to methacholine were assessed. From 1999–2001, study participants were re-contacted to determine symptom status and exposure to a variety of factors, including tobacco smoke, animals, occupational agents and air pollutants (including particulate matter). In a subsample of responders, exposure to house dust-mite allergen was assessed by analysis of dust samples taken from participants' mattresses. In addition, blood samples suitable for deoxyribonucleic acid extraction were collected and stored. Currently, European Community Respiratory Health Survey II is being conducted in 29 centres in 14 countries. At the time of writing this paper, 27 centres had begun the study and ∼12,000 participants had completed a short postal questionnaire, ∼9,000 had completed a more detailed health assessment and 3,500 participants had provided dust samples. Historical air-pollution data have been collated and the programme of monitoring particles with a 50% cut-off aerodynamic diameter of 2.5 µm has been completed in 21 centres in 10 countries.

[1]  C. van Weel,et al.  Interacting effects of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma. , 1991, The American review of respiratory disease.

[2]  D. Jarvis,et al.  The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. , 1997, The Journal of allergy and clinical immunology.

[3]  P. Enright,et al.  Long-term particulate and other air pollutants and lung function in nonsmokers. , 1998, American journal of respiratory and critical care medicine.

[4]  D. Sparrow,et al.  New onset wheezing in an older male population: evidence of allergen sensitization in a longitudinal study. Results of the normative aging study. , 1993, The Journal of allergy and clinical immunology.

[5]  Josep Roca,et al.  References values for forced spirometry , 1998 .

[6]  E. Metter,et al.  Rapid decline in FEV1. A new risk factor for coronary heart disease mortality. , 1995, American journal of respiratory and critical care medicine.

[7]  M. Lebowitz,et al.  Longitudinal changes in allergen skin test reactivity in a community population sample. , 1987, The Journal of allergy and clinical immunology.

[8]  D. Strachan,et al.  The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis II. Observer variation of clinical diagnosis and signs of atopic dermatitis , 1994, The British journal of dermatology.

[9]  Erik Lebret,et al.  Air Pollution Exposure in European Cities: The "Expolis" Study. , 1998 .

[10]  U. Ackermann-Liebrich,et al.  Validity of annoyance scores for estimation of long term air pollution exposure in epidemiologic studies: the Swiss Study on Air Pollution and Lung Diseases in Adults (SAPALDIA). , 2000, American journal of epidemiology.

[11]  R. Hay,et al.  The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation , 1994, The British journal of dermatology.

[12]  G. Guyatt,et al.  Measuring quality of life in asthma. , 1993, The American review of respiratory disease.

[13]  S. Weiss,et al.  Indoor allergens and longitudinal FEV1 decline in older adults: the Normative Aging Study. , 1998, The Journal of allergy and clinical immunology.

[14]  B. Burrows,et al.  The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. , 1980, The American review of respiratory disease.

[15]  M. Chapman,et al.  A two-site monoclonal antibody ELISA for the quantification of the major Dermatophagoides spp. allergens, Der p I and Der f I. , 1989, Journal of immunological methods.

[16]  C E Reed,et al.  A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. , 1992, The American review of respiratory disease.

[17]  D. Johns,et al.  A critical evaluation of the Mefar dosimeter. , 1999, The European respiratory journal.

[18]  D. Jarvis,et al.  The European Community Respiratory Health Survey. , 1994, The European respiratory journal.

[19]  R. F. Leonard,et al.  A critical evaluation of the MefarTM dosimeter , 1999 .

[20]  Deborah Jarvis,et al.  Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). , 1996, The European respiratory journal.

[21]  John E. Ware,et al.  SF-36 physical and mental health summary scales : a user's manual , 1994 .

[22]  E. Walters,et al.  Variation in nebulizer output and weight output from Mefar dosimeter: implications for multicentre studies. , 1997, The European respiratory journal.

[23]  D. Strachan,et al.  International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. , 1995, The European respiratory journal.

[24]  D. Hendrick.  The world wide problem of occupational asthma , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[25]  C. Burchfiel,et al.  Pulmonary function decline and 17-year total mortality: the Honolulu Heart Program. , 1994, American journal of epidemiology.

[26]  S. Weiss,et al.  Skin test reactivity to common aeroallergens and decline of lung function. The Normative Aging Study. , 1996, American journal of respiratory and critical care medicine.

[27]  M. Abramson,et al.  Evaluation of a new asthma questionnaire. , 1991, The Journal of asthma : official journal of the Association for the Care of Asthma.

[28]  B. Rosner,et al.  Predictors of the new onset of wheezing among middle-aged and older men. The Normative Aging Study. , 1993, The American review of respiratory disease.

[29]  F. Speizer,et al.  Cigarette smoking and incidence of chronic bronchitis and asthma in women. , 1995, Chest.

[30]  P. Burney,et al.  Developing a new questionnaire for measuring the prevalence and distribution of asthma. , 1987, Chest.

[31]  Matti Jantunen,et al.  Elemental analysis of airborne particulate matter by ED-XRF within the European EXPOLIS study , 2001 .

[32]  W. Willett,et al.  Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. , 1995, American journal of respiratory and critical care medicine.

[33]  D. Postma,et al.  Adult patients may outgrow their asthma: a 25-year follow-up study. , 1997, American journal of respiratory and critical care medicine.

[34]  A. James,et al.  Decline in lung function and mortality: the Busselton Health Study. , 1999, Journal of epidemiology and community health.

[35]  D. Hendrick,et al.  Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output. , 1990, Thorax.

[36]  F. Kauffmann,et al.  Development of an asthma specific job exposure matrix and its application in the epidemiological study of genetics and environment in asthma (EGEA) , 2000, Occupational and environmental medicine.

[37]  D. Johns,et al.  European Community Respiratory Health Survey calibration project of dosimeter driving pressures , 2002, European Respiratory Journal.

[38]  W S Linn,et al.  A study of twelve Southern California communities with differing levels and types of air pollution. II. Effects on pulmonary function. , 1999, American journal of respiratory and critical care medicine.

[39]  B. Rosner,et al.  Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. , 1995, American journal of respiratory and critical care medicine.